EXHIBIT 11

                 STATEMENT RE COMPUTATION OF EARNINGS PER SHARE

<TABLE>
<CAPTION>
                                                   Three             Three              Nine              Nine
                                                   Months            Months            Months            Months
                                                   Ended             Ended             Ended             Ended
                                                December 27,      December 29,      December 27,      December 29,
                                                  1996 (1)          1995 (1)          1996 (1)          1995 (1)
                                                -----------       -----------       -----------       -----------
<S>                                               <C>               <C>               <C>               <C>      
Weighted average number of common and
 common equivalent shares outstanding:
    Weighted average number of shares of
      common stock outstanding during the
      period                                      4,697,428         3,500,000         4,498,314         3,500,000
    Incremental shares assumed to be
      outstanding related to common stock
      options granted and outstanding,
      excluding options granted within twelve
      months of initial public offering             538,279           345,250           470,492           345,250
    Incremental shares assumed to be
      outstanding related to common
      stock options granted within
      twelve months of initial public
      offering                                       89,000            89,000            89,000            89,000
    Incremental shares assumed to be
      outstanding related to common stock
      warrants issued and outstanding               675,000            40,000           580,256            40,000
    Shares of common stock assumed to be
      purchased upon exercise of outstanding
      options and warrants (2)                     (940,202)         (103,361)         (845,042)         (103,361)
                                                -----------       -----------       -----------       -----------
Weighted average number of common
  and common equivalent shares
  outstanding - Primary earnings per share        5,059,505         3,870,889         4,793,020         3,870,889
Adjustment of number of shares assumed to
  be purchased upon exercise of options and
  warrants based on the closing market price           --                --                --                --
                                                -----------       -----------       -----------       -----------
Weighted average number of common
  and common equivalent shares outstanding -
  Earnings per share assuming full dilution       5,059,505         3,870,889         4,793,020         3,870,889
                                                ===========       ===========       ===========       ===========

Net income (loss)                               $    27,145       $   654,957       $   997,614       $   660,403
Adjustment of interest expense, net of tax
  effect, related to assumed repayment of
  debt obligations due to 20% limitation on
  purchase of shares upon exercise of
  outstanding options and warrants                   21,263              --                --                --
                                                -----------       -----------       -----------       -----------
Net income (loss) as adjusted                   $    48,408       $   654,957       $   997,614       $   660,403
                                                ===========       ===========       ===========       ===========
Net income (loss) per share:
  Primary                                       $      0.01       $      0.17       $      0.21       $      0.17
                                                ===========       ===========       ===========       ===========
  Assuming full dilution                        $      0.01       $      0.17       $      0.21       $      0.17
                                                ===========       ===========       ===========       ===========
</TABLE>

(1)  Computations do not reflect exercise of outstanding options and warrants if
     the effect  thereof  is  anti-dilutive  except as  required  by  Accounting
     Principles Board Opinion No. 15 (APB #15) under the modified treasury stock
     method,  and except as  required  by  Securities  and  Exchange  Commission
     Accounting  Bulletin  Topic 4D,  stock  options  granted  during the twelve
     months prior to the Company's  initial public  offering at prices below the
     public  offering  price have been included in the  calculation  of weighted
     average  shares  of  common  stock as if they  were  outstanding  as of the
     beginning of the periods presented.

(2)  Shares of common stock assumed to be purchased  with proceeds upon exercise
     of outstanding options and warrants is based on the average market price of
     the  Company's  common stock during the period and is limited to 20% of the
     number of common shares outstanding at the end of the period, if applicable
     in accordance with APB #15.